TEMPLATE DESIGN © 2008 www.PosterPresentations.co m A CASE SERIES ANALYSIS OF RENAL OUTCOME FOR FIXED VERSUS ADJUSTABLE DOSE OF CONTINUOUS RENAL REPLACEMENT.

Slides:

Advertisements

Similar presentations

A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.

Advertisements

Introduction to Nephrology Sandeep K. Shori, D.O. Dialysis Associates Fort Worth, TX.

The golden hour(s) for severe sepsis and septic shock treatment

Nallasamy K, Jayashree M, Singhi S, Bansal A

Myeloma and Renal Disease

REMEDIAL II Renal Insufficiency Following Contrast Media Administration Trial II (REMEDIAL II): RenalGuard™ System In High-Risk Patients for Contrast-Induced.

 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.

Acute kidney injury R3 李岳庭 / F1 王奕淳 / VS 林景坤 Brenner and Rector's The Kidney, 8th ed P 高雄長庚腎臟科 Journal reading.

The long-term outcome after acute renal failure Presented by Ri 顏玎安.

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.

1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.

Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.

Single Unit Transfusion Guideline for Red Blood Cell Transfusion

A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.

Fluid Overload and Acute Kidney Injury Kathleen D. Liu February 18, 2014.

Corticosteroid dosing in the treatment of acute exacerbations of COPD Kurt A. Wargo, Pharm.D., BCPS, Takova D. Wallace, Pharm.D. Candidate 2014, Ryan E.

 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.

References Results Methods Purpose Incidence and Clinical Course of Acute Kidney Injury in Adult Patients with Severe Trauma SeungJee Ryu*, Young Ok Kim*,

Immunomodulation of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy Sasipha Tachaboon 1, Khajohn Tiranatanakul.

Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.

ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:

Critical Appraisal Athar Yasin EOE - RTD Jan 2012.

A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:

A Randomized Trial of Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Schulman S et al. Proc ASH 2011;Abstract 205.

Excessive fluid is not needed: So why is Dr. Durward so wasteful? Timothy E Bunchman MD Professor & Director Pediatric Nephrology

Major Clinical Trials in AKI Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.

Bicarbonate-Based Solutions in the Management of Acute Kidney Injury Vania Cecilia Prudencio-Ribera, MD 1 ; Universidad Mayor de San Simón, School of Medicine,

THE EFFECT OF TIMING OF INITITIATION OF CRRT ON PATIENTS REQUIRING EXTRA-CORPOREAL MEMBRANE OXYGENATION (ECMO) Asif Mansuri, MD, MRCPI Fellow, Division.

Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.

Interobserver Reliability of Acute Kidney Injury Network (AKIN) criteria A single center cohort study Figure 2 The acute kidney injury network (AKIN) criteria.

Dr Sam Ley CT2 ICM Dr Radha Sundaram Consultant ICM Royal Alexandra Hospital, Paisley, Scotland.

Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.

COMET: Carvedilol Or Metoprolol European Trial Purpose To compare the effects of carvedilol (a β 1 -, β 2 - and α 1 -receptor blocker) and short-acting.

Haemofiltration for sepsis: burial or resurrection?

Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.

Poster Design & Printing by Genigraphics ® A Comparison of the Effects of Etomidate and Midazolam on the Duration of Vasopressor Use in.

Proposal of a flow-chart to avoid circuit clotting in prolonged intermittent renal replacement therapy (PIRRT): a monocentric experience 1 Vincenzo Cantaluppi,

Implementation of RRT improved the survival rate significantly, when blood urea nitrogen or serum creatinine was still low level. However, most of those.

Long-term mortality and thrombolysis therapy after a first acute ischemic stroke: gender differences. Ebrictus II Study. Authors & Affiliations Clua-Espuny.

Results Methods Abstract Number 69 Objectives 1.Nephrol Dial Transplant (2011) 26: 537–543 2.J Support Oncol 2011;9:149–155 3.N Engl J Med. 2009; 361:1627–1638.

Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,

Retrospective Monocentric 10-Year Analysis Of Sepsis-Associated Acute Kidney Injury: Impact On Outcome, Dialysis Dose And Residual Renal Function 1 Vincenzo.

Role of CRRT in Sepsis Dr Apoorva Jain Agra.

STUDY OF THE RISK FACTORS OF ACUTE REJECTION AFTER LIVE DONOR RENAL TRANSPLANTATION:A SINGLE EGYPTIAN CENTER EXPERIENCE Ayman M Nagib¹, Ahmed S Elsaied¹,

Risk Factors for Linezolid-Associated Thrombocytopenia in Adult Patients Cristina Gervasoni Ospedale Luigi Sacco, Milano.

Anything else? Glucose – tight control must be better NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill.

Poster Title Acute Kidney Injury (AKI) biomarkers increased in pre-renal AKI. Although the concept of “ pre-renal azotaemia ” is ingrained into clinical.

Response to An Initial Dose of Warfarin in Thai Patients Undergoing Long-Term Anticoagulant Therapy Weerayuth Saelim R.Ph. 2 nd year Pharmacy resident.

Renal Replacement Therapy for Prevention of Contrast- induced Acute Kidney Injury: A Meta-analysis of Randomized Controlled Trials Source Song K, Jiang.

An AKI project for critically ill cancer patients

University of Alabama at Birmingham

CRRT (Continuous Renal Replacement Therapy)

Impact Of Intensity Of Glucose Control On Lactate Levels In Children After Cardiac Surgery Fule BK1, Kanthimathinathan HK3 Gan CS1, Davies P2, Laker S1,

AKI in critically ill cancer patients:

RIFLE criteria for acute kidney injury

Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal Blood Purif 2017;44: DOI: / Fig.

Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.

DEBATE: Timing of CRRT in Critical Care

Primary end point of the ANZICS low-dose dopamine trial

Mannitol and current trends in fluid management

Feeding Modality is a Barrier to Providing Adequate Protein to Pediatric Patients Receiving Continuous Renal Replacement Therapy Molly Wong Vega, MS, RDN.

Objectives Early initiation of continuous renal replacement therapy

T.Zaoral,M.Hladík, M.Sádlo, V.Vobruba

Figure 2 Milestones in paediatric acute kidney injury (AKI) research

Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.

SIGNIFY Trial design: Participants with stable coronary artery disease without clinical heart failure and resting heart rate >70 bpm were randomized to.

Volume 80, Issue 7, Pages (October 2011)

Renal Replacement Therapy in Acute Kidney Injury

Volume 70, Issue 7, Pages (October 2006)

Consultant Clinical Biochemist

Presentation transcript:

TEMPLATE DESIGN © m A CASE SERIES ANALYSIS OF RENAL OUTCOME FOR FIXED VERSUS ADJUSTABLE DOSE OF CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY A CASE SERIES ANALYSIS OF RENAL OUTCOME FOR FIXED VERSUS ADJUSTABLE DOSE OF CONTINUOUS RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY Mohammad Faisal A 1, Wan Hasnul WH 1, Nazmi Liana A 2, Fadhleena Y 3. 1 Nephrology Unit, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia. 2 Clinical Research Centre, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia. 3 Department of Pharmacy, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia. Introduction Objectives We conducted a cross sectional study from 1 to 31 January 2015 involving 10 patients admitted to Hospital Raja Perempuan Zainab II, Kelantan with AKI that required CRRT. Among them, 4 patients were given adjustable dose of effluent fluid while another 6 patients received fixed dose of effluent fluid during treatment. Results Conclusion The findings suggested that the more economical adjustable dose of CRRT can be applied to AKI patients as it did not display any significant differences in renal outcomes. A larger trial should be carried out to further evaluate its effectiveness, safety and dosage adjustment methods. Results Table 1: Demographic data The objective of this study was to evaluate renal outcomes in patients with acute kidney injury (AKI) towards fixed dose versus adjustable dose of CRRT throughout the treatment. 1.Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26–30. 2.VA/NIH Acute Renal Failure Trial Network, Palevsky PM et all, Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7–20. 3.RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal- replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627– Maynar-Moliner J, Sanchez-Izquierdo-Riera JA, Herrera-Gutierrez M: Renal support in critically ill patients with acute kidney injury [letter]. N Engl J Med 2008; 359: 1960; author reply 1961– Plaevsky PM et al. Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. Crit Care 2009; 13: 310. VariableFixed dose (n=6) Adjustable dose (n=4) Age (mean)45 (SD=) years old48 (SD=) years old RaceMalay, n=6Malay, n=4 Gender Male, n=5 Female, n=1 Male, n=2 Female, n=2 Cause of AKISepsis, n=6Sepsis, n=4 Adverse effect Fixed dose (n=6) Adjustable dose (n=4) p-value Clotting16% (n=1)25% (n=1)0.12 a Death50% (n=2) 0.67 a Renal outcomesFixed dose (n=6) Adjustable dose (n=4) p-value Recovery of urine ouput16% (n=1)50% (n=2)0.79 a Improvement of creatinine level66%(n=4)75% (n=3)1.27 a Table 2: Association between fixed and adjustable dose of CRRT with adverse effect Table 3: Association between fixed and adjustable dose of CRRT with renal outcome a=chisquare Graph : Differences between gender in fixed versus adjustable dose of CRRT Number of patients Methodology a=chisquare Discussion Fixed dose of continuous renal replacement therapy (CRRT) between 20 – 35 ml/kg/hr has been shown to improve renal function and reduces mortality 1. Studies showed that lower or higher dose of CRRT were not associated with better outcomes 2. To date, the optimal dose for CRRT continues to be controversial. Practice patterns vary widely among institutions as they tend to be influenced by evidences from recent clinical trials. In 2008, Maynar- Moliner J and associates raised an intriguing question as whether fixed dose is appropriate throughout the dynamic course of AKI. Palevsky PM et al believed that the theory was untested and required meticulous evaluation.